Technological advancement in the healthcare sector has empowered doctors with previously unimaginable medical procedures. One such deal with heart transplant. Heart transplant market is experiencing a sudden boost due to the transforming associated market. The process involves the removal of a diseased heart and replacement of it with the heart of a deceased person. This process increases life expectancy by years and is revolutionary in its own accord. The global heart transplant market can experience a robust CAGR of 11.2% during the forecast period (2017-2023), claims Market Research Future (MRFR) in an extensively studied report. It further includes a detailed analysis of drivers and segments to have a better prediction for the future market. Among the drivers, poor heart condition owing to cough-especially at night, poor exercise tolerance, shortness of breath, fatigue, and fluid retention can be considered primarily.
However, the procedure is quite expensive and the availability of heart at the right moment is one big factor that is controlling the market. This can hold back the market growth during the forecast period.
The global heart transplant market can be segmented by types and end-user.
Based on types, the heart transplant market is segmented into ventricular assist devices, total artificial hearts, and others.
Based on end-user, the heart transplant market is segmented into hospital, cardiac institute, and others
Heart Transplant Market Regional Analysis
Region-specific analysis of the heart transplant market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas is currently leading the market from the front with well-developed technology to back up its progress. High healthcare spending and substantial funding from the government are reasons behind the regional growth. Private investment is also impacting the market significantly. According to the International Society for Heart and Lung Transplantation in 2016, around 444 people up to age 17 got their heart transplanted in the U.S. alone.
Europe assumes the second position with governments increasing their healthcare expenditure by significant margins. The market is getting driven by investments made by France and Germany.
The APAC is experiencing a complete upheaval. The region is experiencing exponential growth in the healthcare sector owing to countries such as India emerging as a medical tourism hub and are investing heavily in the industry.
However, the MEA is only going to register a nominal growth due to the poor socio-economic condition of the region.
Heart Transplant Market Players
·Globus Medical, Inc. (U.S.)
·Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
·Smith & Nephew plc. (UK)
·NuVasive, Inc. (U.S.)
·Stryker Corporation (U.S.)
·Integra LifeSciences Holdings Corporation (U.S.)
·Zimmer Biomet Holdings, Inc. (U.S.)
·Medtronic, plc (Ireland)
·Wright Medical Group N.V. (Netherlands)
·The Orthopedic Implant Company (U.S.)
·Aesculap Implant Systems (U.S.)
·Conmed Corporation (U.S.)
·BioTek Instruments, Inc. (U.S.)
·Arthrocare Corporation (U.S.)
among others are some key companies in the global heart transplant that are listed by MRFR for market research.
Browse Detailed TOC with COVID-19 Impact Analysis at:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),